Peijia Medical Executive and Leadership Team

Michael Zhang, the Chairman & Chief Executive Officer at Peijia Medical, directs the overarching corporate strategy and global operations. Zhang guides the company's mission to deliver innovative medical products, particularly high-end devices for structural heart disease and neurovascular interventions. This leadership involves setting the vision for product development, market expansion, and ensuring the company's commitment to providing safe, effective, and accessible solutions. Michael Zhang oversees the strategic alignment of all departments, ensuring that the company's efforts directly contribute to improving patient quality of life. The Chairman & Chief Executive Officer's role is critical in navigating the competitive landscape of medical technology and solidifying Peijia Medical's position as a global provider.

Leo Tsai, the Chief Financial Officer at Peijia Medical, manages all financial aspects of the global organization. Tsai oversees financial planning, budgeting, and reporting, ensuring fiscal responsibility across all operations. This role involves managing capital allocation, investor relations, and driving financial strategies that support the company's growth objectives in the medical device sector. The Chief Financial Officer ensures that financial operations align with Peijia Medical's commitment to innovation and accessibility for patients with cardiovascular and neurovascular diseases. Leo Tsai's expertise is vital for maintaining financial health and enabling the company to invest in cutting-edge medical technologies and expand its reach to hospitals and healthcare providers worldwide.

Karl Pan, the Chief Operating Officer at Peijia Medical, directs the execution of the company's operational strategies and manufacturing processes. Pan oversees the efficient production and delivery of Peijia Medical's comprehensive range of products, including aortic, mitral, and tricuspid valves, as well as neurovascular intervention products. This leadership ensures that the company maintains high standards of quality and safety in its medical devices, supporting healthcare providers dealing with critical cardiovascular and neurovascular conditions. Karl Pan's focus is on optimizing supply chain management and manufacturing efficiency to meet global demand. The Chief Operating Officer plays a crucial part in translating technological advancements into tangible, accessible solutions that improve patient outcomes and enhance the company's market presence.

JianFong Tan, the Chief Technology Officer at Peijia Medical, spearheads the company's technological innovation and research and development initiatives. Tan leads the advancement of high-end medical devices within the structural heart disease and neurovascular intervention fields. This involves directing the development of new product lines, including innovative valve technologies and sophisticated neurovascular intervention tools. The Chief Technology Officer ensures that Peijia Medical remains at the forefront of medical technology, focusing on creating safe, effective, and accessible solutions. JianFong Tan's vision drives the continuous improvement of existing products and the exploration of novel approaches to address unmet patient needs, reinforcing the company's commitment to enhancing patient quality of life globally.